| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 199.352 | 195.184 | 221.200 | 146.494 | 130.005 | 108.857 | 153.019 | 212.924 | 228.464 | 266.476 |
| Total Income - EUR | 199.578 | 195.674 | 221.363 | 146.700 | 130.005 | 148.486 | 197.302 | 213.445 | 228.586 | 269.401 |
| Total Expenses - EUR | 180.936 | 174.973 | 211.031 | 168.872 | 151.492 | 143.335 | 178.109 | 194.344 | 224.584 | 254.731 |
| Gross Profit/Loss - EUR | 18.641 | 20.702 | 10.333 | -22.173 | -21.486 | 5.151 | 19.193 | 19.101 | 4.003 | 14.670 |
| Net Profit/Loss - EUR | 17.709 | 17.200 | 8.215 | -23.639 | -22.784 | 4.023 | 17.218 | 17.009 | 2.060 | 12.357 |
| Employees | 5 | 5 | 5 | 5 | 5 | 4 | 5 | 5 | 5 | 5 |
Check the financial reports for the company - Da Vinci Medical Concept Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 39.178 | 29.015 | 21.710 | 15.187 | 9.084 | 13.036 | 9.857 | 9.426 | 6.862 | 89.646 |
| Current Assets | 7.010 | 12.541 | 11.878 | 6.750 | 6.017 | 9.330 | 5.892 | 20.396 | 19.277 | 53.554 |
| Inventories | 2.524 | 2.606 | 3.897 | 3.044 | 2.339 | 2.706 | 1.294 | 549 | 1.542 | 1.761 |
| Receivables | 4.337 | 2.758 | 2.712 | 1.838 | 1.495 | 3.538 | 3.561 | 3.669 | 4.172 | 16.393 |
| Cash | 149 | 7.177 | 5.269 | 1.868 | 2.183 | 3.087 | 1.037 | 16.177 | 13.563 | 35.400 |
| Shareholders Funds | -5.797 | 11.463 | 19.505 | -4.492 | -27.189 | -22.568 | -4.850 | 12.145 | 11.531 | 16.827 |
| Social Capital | 67 | 67 | 88 | 86 | 84 | 165 | 162 | 162 | 162 | 161 |
| Debts | 52.045 | 30.154 | 15.461 | 26.523 | 42.375 | 45.067 | 20.690 | 17.767 | 14.608 | 126.373 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Da Vinci Medical Concept Srl